These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
708 related articles for article (PubMed ID: 17950005)
1. Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Paget C; Mallevaey T; Speak AO; Torres D; Fontaine J; Sheehan KC; Capron M; Ryffel B; Faveeuw C; Leite de Moraes M; Platt F; Trottein F Immunity; 2007 Oct; 27(4):597-609. PubMed ID: 17950005 [TBL] [Abstract][Full Text] [Related]
2. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. Schleicher U; Liese J; Knippertz I; Kurzmann C; Hesse A; Heit A; Fischer JA; Weiss S; Kalinke U; Kunz S; Bogdan C J Exp Med; 2007 Apr; 204(4):893-906. PubMed ID: 17389237 [TBL] [Abstract][Full Text] [Related]
3. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis. Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286 [TBL] [Abstract][Full Text] [Related]
4. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation. Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356 [TBL] [Abstract][Full Text] [Related]
5. Essential role of Toll-like receptors for dendritic cell and NK1.1(+) cell-dependent activation of type 1 immunity by Lactobacillus pentosus strain S-PT84. Koizumi S; Wakita D; Sato T; Mitamura R; Izumo T; Shibata H; Kiso Y; Chamoto K; Togashi Y; Kitamura H; Nishimura T Immunol Lett; 2008 Oct; 120(1-2):14-9. PubMed ID: 18620001 [TBL] [Abstract][Full Text] [Related]
6. Role of marginal zone B lymphocytes in invariant NKT cell activation. Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762 [TBL] [Abstract][Full Text] [Related]
7. Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. Sawaki J; Tsutsui H; Hayashi N; Yasuda K; Akira S; Tanizawa T; Nakanishi K Int Immunol; 2007 Mar; 19(3):311-20. PubMed ID: 17289654 [TBL] [Abstract][Full Text] [Related]
8. Immunostimulatory RNA oligonucleotides induce an effective antitumoral NK cell response through the TLR7. Bourquin C; Schmidt L; Lanz AL; Storch B; Wurzenberger C; Anz D; Sandholzer N; Mocikat R; Berger M; Poeck H; Hartmann G; Hornung V; Endres S J Immunol; 2009 Nov; 183(10):6078-86. PubMed ID: 19890064 [TBL] [Abstract][Full Text] [Related]
9. Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity. Suzuki Y; Wakita D; Chamoto K; Narita Y; Tsuji T; Takeshima T; Gyobu H; Kawarada Y; Kondo S; Akira S; Katoh H; Ikeda H; Nishimura T Cancer Res; 2004 Dec; 64(23):8754-60. PubMed ID: 15574787 [TBL] [Abstract][Full Text] [Related]
10. TLR2 promotes Th2/Th17 responses via TLR4 and TLR7/8 by abrogating the type I IFN amplification loop. Wenink MH; Santegoets KC; Broen JC; van Bon L; Abdollahi-Roodsaz S; Popa C; Huijbens R; Remijn T; Lubberts E; van Riel PL; van den Berg WB; Radstake TR J Immunol; 2009 Dec; 183(11):6960-70. PubMed ID: 19915052 [TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor-dependent IL-12 production by dendritic cells is required for activation of natural killer cell-mediated Type-1 immunity induced by Chrysanthemum coronarium L. Tanaka S; Koizumi S; Masuko K; Makiuchi N; Aoyagi Y; Quivy E; Mitamura R; Kano T; Ohkuri T; Wakita D; Chamoto K; Kitamura H; Nishimura T Int Immunopharmacol; 2011 Feb; 11(2):226-32. PubMed ID: 21144920 [TBL] [Abstract][Full Text] [Related]
14. Role of invariant NK T lymphocytes in immune responses to CpG oligodeoxynucleotides. Paget C; Bialecki E; Fontaine J; Vendeville C; Mallevaey T; Faveeuw C; Trottein F J Immunol; 2009 Feb; 182(4):1846-53. PubMed ID: 19201836 [TBL] [Abstract][Full Text] [Related]
15. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7. Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792 [TBL] [Abstract][Full Text] [Related]
16. H2-D(d)-mediated upregulation of interleukin-4 production by natural killer T-cell and dendritic cell interaction. Mizuuchi K; Yanagawa Y; Iwabuchi K; Namba K; Kitaichi N; Ohno S; Onoé K Immunology; 2008 May; 124(1):102-11. PubMed ID: 18194275 [TBL] [Abstract][Full Text] [Related]
17. Dendritic cell internalization of α-galactosylceramide from CD8 T cells induces potent antitumor CD8 T-cell responses. Choi DH; Kim KS; Yang SH; Chung DH; Song B; Sprent J; Cho JH; Sung YC Cancer Res; 2011 Dec; 71(24):7442-51. PubMed ID: 22028323 [TBL] [Abstract][Full Text] [Related]
18. Activation of decidual invariant natural killer T cells promotes lipopolysaccharide-induced preterm birth. Li L; Yang J; Jiang Y; Tu J; Schust DJ Mol Hum Reprod; 2015 Apr; 21(4):369-81. PubMed ID: 25589517 [TBL] [Abstract][Full Text] [Related]
19. Recognition of bacterial glycosphingolipids by natural killer T cells. Kinjo Y; Wu D; Kim G; Xing GW; Poles MA; Ho DD; Tsuji M; Kawahara K; Wong CH; Kronenberg M Nature; 2005 Mar; 434(7032):520-5. PubMed ID: 15791257 [TBL] [Abstract][Full Text] [Related]
20. Optimal TLR9 signal converts tolerogenic CD4-8- DCs into immunogenic ones capable of stimulating antitumor immunity via activating CD4+ Th1/Th17 and NK cell responses. Zhang X; Munegowda MA; Yuan J; Wei Y; Xiang J J Leukoc Biol; 2010 Aug; 88(2):393-403. PubMed ID: 20466823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]